Franziska Krummenast

Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT

Johannes Duell, Franziska Krummenast, Andreas Schirbel et al. · Journal of Nuclear Medicine · 2021 · 64 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Carfilzomib Based Treatment Strategies in the Management of Relapsed/Refractory Multiple Myeloma with Extramedullary Disease

Xiang Zhou, Patricia Flüchter, Katharina Nickel et al. · Cancers · 2020 · 43 citations · Full text

Medicine, Oncology, Pharmacology +13

Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

Maximilian Steinhardt, Eliza Wiercinska, Manh Van Pham et al. · Journal of Translational Medicine · 2020 · 40 citations · Full text

Life Sciences, Hematology, Immunology +13

The impact of pyrvinium pamoate on colon cancer cell viability

Armin Wiegering, Friedrich-Wilhelm Uthe, Melanie Hüttenrauch et al. · International Journal of Colorectal Disease · 2014 · 38 citations

Medicine, Oncology, Pharmacology +6

Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab (“Pom‐PAD‐Dara”) in relapsed/refractory multiple myeloma

Xiang Zhou, Maximilian Steinhardt, Denise Grathwohl et al. · Cancer Medicine · 2020 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +16